I was reminded this morning of the " beautiful sto
Post# of 148183
Safety Yes!
Tolerability Yes!
Efficacy Yes!
Patient presents with many symptoms and gets Leronlimab or placebo ( SOC)
MM- will show improvement with many endpoints and 2ndary endpoints with good P values for each I believe. They will break out the end points and compare to placebo. Will tell a great story when looked at as a whole.
S/C- will show improvement in Mortality and again drug safety. Will be final chapter for Acute Covid.
Long Haulers- potential trial- No doubt successful Addendum to the story.
This is a true story, facts based on clinical trial evidence that has a great ending.
This will happen, this is the beautiful story BP mentioned IMHO. I believe this is why CYDY et al seem so calm and confident.